162 related articles for article (PubMed ID: 36718709)
1. [Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].
Zhou QJ; Gong P; Jiao XR; Yang ZX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):181-185. PubMed ID: 36718709
[TBL] [Abstract][Full Text] [Related]
2. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.
Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J
BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173
[TBL] [Abstract][Full Text] [Related]
3. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
4. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
5. Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P gene.
Fridman C; Hosomi N; Varela MC; Souza AH; Fukai K; Koiffmann CP
Am J Med Genet A; 2003 Jun; 119A(2):180-3. PubMed ID: 12749060
[TBL] [Abstract][Full Text] [Related]
6. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family.
Wang Y; Chang Y; Gao M; Zang W; Liu X
Hereditas; 2024 Feb; 161(1):8. PubMed ID: 38317267
[TBL] [Abstract][Full Text] [Related]
8. Albinism and developmental delay: the need to test for 15q11-q13 deletion.
Saadeh R; Lisi EC; Batista DA; McIntosh I; Hoover-Fong JE
Pediatr Neurol; 2007 Oct; 37(4):299-302. PubMed ID: 17903679
[TBL] [Abstract][Full Text] [Related]
9. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of retinopathy of prematurity in oculocutaneous albinism with OCA2 variants: a case report and review of literature.
Zheng XY; Wu DW; Yu L; Zhao ZY
BMC Pediatr; 2024 Jun; 24(1):390. PubMed ID: 38858617
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
[TBL] [Abstract][Full Text] [Related]
13. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
14. Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism.
Jiang B; Zhang H; Kan Y; Gao X; Du Z; Liu Q
Mol Genet Genomic Med; 2024 Jan; 12(1):e2297. PubMed ID: 37882226
[TBL] [Abstract][Full Text] [Related]
15. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
[TBL] [Abstract][Full Text] [Related]
16. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
[TBL] [Abstract][Full Text] [Related]
17. Novel deletion of exon 3 in TYR gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations.
Dhangar S; Panchal P; Ghatanatti J; Suralkar J; Shah A; Vundinti BR
BMC Med Genomics; 2022 Jan; 15(1):2. PubMed ID: 34980106
[TBL] [Abstract][Full Text] [Related]
18. P gene mutations associated with oculocutaneous albinism type II (OCA2).
Oetting WS; Garrett SS; Brott M; King RA
Hum Mutat; 2005 Mar; 25(3):323. PubMed ID: 15712365
[TBL] [Abstract][Full Text] [Related]
19. Nystagmus and Foveal Hypoplasia in a Carrier of Oculocutaneous Albinism.
Arora N; Hoyek S; Patel NA
Ophthalmic Surg Lasers Imaging Retina; 2024 Jun; 55(6):349-353. PubMed ID: 38860972
[TBL] [Abstract][Full Text] [Related]
20. Inheritance of a novel mutated allele of the OCA2 gene associated with high incidence of oculocutaneous albinism in a Polynesian community.
Johanson HC; Chen W; Wicking C; Sturm RA
J Hum Genet; 2010 Feb; 55(2):103-11. PubMed ID: 20019752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
